(NASDAQ: PSNL) Personalis's forecast annual revenue growth rate of 35.75% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 9.16%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 8.76%.
Personalis's revenue in 2023 is $65,047,000.On average, 3 Wall Street analysts forecast PSNL's revenue for 2023 to be $3,951,084,871, with the lowest PSNL revenue forecast at $3,813,725,328, and the highest PSNL revenue forecast at $4,043,623,795. On average, 2 Wall Street analysts forecast PSNL's revenue for 2024 to be $5,670,719,794, with the lowest PSNL revenue forecast at $5,406,983,863, and the highest PSNL revenue forecast at $5,934,502,463.
In 2025, PSNL is forecast to generate $7,697,462,427 in revenue, with the lowest revenue forecast at $7,697,462,427 and the highest revenue forecast at $7,697,462,427.